Navigation Links
Otonomy Announces Preclinical Results Supporting Intra-operative Use of OTO-201 for Common Childhood Procedure
Date:6/8/2011

SAN DIEGO, June 8, 2011 /PRNewswire/ -- Otonomy, Inc., a developer of innovative therapeutics for diseases and disorders of the ear, today announced positive results for OTO-201, a sustained release gel formulation of the antibiotic ciprofloxacin, in multiple preclinical studies evaluating the treatment of middle ear effusion (fluid) at the time of tympanostomy tube placement surgery.  Approximately one million tube placement procedures are conducted each year in the U.S. with the vast majority performed in children suffering from recurrent or persistent otitis media (inflammation or infection of the middle ear). A significant portion of patients receiving tubes have middle ear effusion at the time of surgery which significantly increases their risk of post-operative complications including otorrhea (drainage) and tube occlusion. A number of clinical studies have demonstrated that administration of topical antibiotics during and immediately following tube placement surgery significantly reduces this risk. However, no antibiotic product has been approved by the United States Food and Drug Administration (FDA) for this use and efficacy relies on caregiver compliance with multi-day dosing regimens. OTO-201 is a sustained release antibiotic designed for intra-operative administration by the ear, nose and throat (ENT) surgeon, thereby providing a full course of treatment at the time of tube placement and eliminating the risk of compliance issues.

Preclinical study results demonstrating sustained middle ear drug exposure and efficacy of OTO-201 were presented yesterday at the 10th International Symposium on Recent Advances on Otitis Media. Data demonstrated that a single administration of OTO-201 delivered ciprofloxacin concentrations to the middle ear that were sustained for more than one week above the minimum inhibitory concentration (MIC) required for eradication of common otitis media pathogens. Findings in an otitis media model confirmed that
'/>"/>

SOURCE Otonomy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer
2. Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C
3. Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics
4. Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation
5. Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
6. Alere Inc. Announces Extension of Consent Solicitations Related to its 9.0% Senior Subordinated Notes Due 2016, 8.625% Senior Subordinated Notes Due 2018 and 7.875% Senior Notes Due 2016 and Increased Consent Fees
7. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
8. Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA
9. Ore Pharmaceutical Holdings Announces Name Change and Reverse/Forward Stock Split to be Effective June 10, 2011
10. Thoratec Announces Presentations at Upcoming Investor Conferences
11. COPAN Announces Strategic Global Distribution Partnership with Siemens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Today at American Society for ... Ginocchio discussed Specific Technologies blood culture ... of microorganisms producing bloodstream infection. Dr. Ginocchio is ... Division of Infectious Disease Diagnostics at North Shore-LIJ ... health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ) ...
(Date:5/20/2013)... Calif. , May 20, 2013 /PRNewswire-iReach/ -- ... of the first study demonstrating detection of pathogenic ... Yersinia pestis and Bacillus anthracis ... and Prevention,s list of potential bio-threats. This seminal ... and Technology Laboratory, Salisbury ...
(Date:5/20/2013)... , May 20, 2013  Hill-Rom Holdings, Inc. (NYSE: ... a management presentation at the 38 th Annual ... on May 30, 2013, at 1:30 p.m. ... You are invited to listen to the live ... or access it directly at http://www.media-server.com/m/p/f7bj3q84 . A ...
Breaking Medicine Technology:Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2
... 7, 2011 Rochester Medical Corporation (NASDAQ: ... the previously announced purchase of Laprolan B.V., the former ... BioSciences N.V. Under the terms of the purchase agreement ...  For more information regarding this transaction please refer to ...
... April 7, 2011 Ascension Orthopedics, Inc., a world ... the TITAN Modular Total Shoulder.  The surgeries were performed ... Baltimore, MD.     "I have been ... of years in my practice. Now that Ascension has ...
Cached Medicine Technology:Ascension Orthopedics Announces TITAN™ Modular Shoulder Implantations at Union Memorial Hospital 2
(Date:5/20/2013)... DC (PRWEB) May 20, 2013 Medicare ... are overwhelmingly satisfied, citing lower costs, convenient access to ... from Hart Research Associates released today by the Pharmaceutical ... D seniors (9.5 million) are currently enrolled in plans ... pharmacy choices, and overall value of plans with preferred ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 A new ... by MedEx Direct, the creators of the MedEx Pack ... the Benefits of Pharmacy Home Delivery, in order to provide ... their prescriptions are handled. Clyde Furuta, MedEx Direct owner ... home delivery is that with a product like the MedEx ...
(Date:5/20/2013)... improved health care and significant reductions in drug costs ... between physicians and drug company representatives who promote the ... This system, which has been in place for decades, ... to date on new medications, and always provided generous ... the newest drugs, as well as other supplies and ...
(Date:5/20/2013)... T.E.N. announced today that it would ... Security Executive® Northeast Awards now through Friday, July ... Security Executive® of the Year and ISE® People’s ... a positive impact on their organizations through risk ... security; and the ISE® Project of the Year, ...
(Date:5/20/2013)... Geneva, Switzerland (PRWEB) May 20, 2013 ... discovery for lead identification and cell line development for ... that the Company’s co-founder will present data on the ... Development & Engineering Conference, May 20 - 23 ... La Jolla, California. Selexis’ co-founder and scientific advisory board ...
Breaking Medicine News(10 mins):Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 2Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 3Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 3
... Children, WASHINGTON, Oct. 3 Campaign for ... veto of the,Children,s Health Insurance Program Reauthorization bill ... nation,s broken health care systems. The bill,the president ... for 6.6 million children and provide coverage to ...
... Information,Systems, Inc., (Nasdaq: MEDW ) announced that ... the company regarding the company,s,non-compliance with Nadsaq Marketplace ... company,s audit committee. This issue arose,due to the ... an audit,committee member. On October 2, 2007, ...
... say , WEDNESDAY, Oct. 3 (HealthDay News) -- Identifying ... the best chemotherapy for patients, U.S. research suggests. , ... most likely to respond to standard first-line therapy and ... a second-line therapy, based on gene expression profiling," lead ...
... outcomes for high-risk patients , , WEDNESDAY, Oct. 3 (HealthDay ... the bare-metal kind for high-risk patients with blocked coronary ... of restenosis -- having the artery become blocked again ... following two years for those getting drug-coated stents, 7.4 ...
... Oct. 3 Abaxis, Inc.,(Nasdaq: ABAX ), ... systems, announced today the launch of the Kidney,Check ... Piccolo xpress(TM) point of,care analyzer. The new ... and,radiology centers in the United States to determine ...
... Nowhere are the,consequences of premature birth more evident than ... the next week, 563 babies,will be born too soon ... watch their babies be admitted into a NICU. Having ... the most frightening and overwhelming,experiences a parent faces. ...
Cached Medicine News:Health News:Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market 2Health News:Gene Tests Match Up Lung Tumors, Best Treatment 2Health News:Study Finds Benefits With Drug-Coated Stents 2Health News:Study Finds Benefits With Drug-Coated Stents 3Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 2Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 3Health News:March of Dimes NICU Family Support(R) Programs Give Florida Families Comfort and Information During a Crisis 2
... The innovative E.coli ... Pro-Lab offers definitive identification ... the use of a ... the possibility of cross-reactions ...
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
The Oxoid Legionella Latex Test is a latex agglutination test for the identification of predominant Legionella species grown on plate media from patients with suspected Legionellosis or from environm...
Inquire...
Medicine Products: